IOBTQ · IO Biotech, Inc.
$0.00
At close · Jul 27
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has concluded that the aforementioned conditions, among others, raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date the financial statements are issued and therefore, the Company may not be able to continue its currently ongoing research and development activities as planned and realize its assets and satisfy its liabilities in the normal course of business.”View the 10-Q filed Nov 14, 2025
Market Cap
$71,948
Shares
71.95M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mai-Britt Zocca | CEO | $1,839,811 |
| Qasim Ahmad | Chief Medical Officer | $1,057,504 |
| Amy Sullivan | CFO | $998,412 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mai-Britt Zocca | CEO | $1,645,088 |
| Eva Ehrnrooth | Chief Medical Officer | $967,722 |
| Qasim Ahmad | Chief Medical Officer | $920,756 |
| Devin W. Smith | General Counsel | $917,300 |
| Amy Sullivan | CFO | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Mai-Britt Zocca | CEO | $733,875 |
| Amy Sullivan | CFO | $635,173 |
| Eva Ehrnrooth | Chief Medical Officer | $565,840 |
| General Counsel | — | — |
| Qasim Ahmad | Chief Medical Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mai-Britt Zocca | CEO | $8,153,333 |
| Eva Ehrnrooth | Chief Medical Officer | $2,704,051 |
| Muhammad Al-Hajj | Chief Scientific Officer | $2,678,227 |
| Amy Sullivan | CFO | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Eva Ehrnrooth | Chief Medical Officer | $450,127 |
| Mai-Britt Zocca | CEO | $409,349 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Amy Sullivan | Chief Financial Officer | Terminated | 2026-03-31 |
| Amy Sullivan | Chief Accounting Officer | Terminated | 2026-03-31 |
| Heidi Hunter | member of the Board of Directors | Resigned | 2026-03-31 |
| Mai-Britt Zocca | Chief Executive Officer | Terminated | 2026-03-31 |
| David Smith | member of the Board of Directors | Resigned | 2026-03-31 |
| Helen Collins | member of the Board of Directors | Resigned | 2026-03-31 |
| Kathleen Glaub | member of the Board of Directors | Resigned | 2026-03-31 |
| Christian Elling | member of the Board of Directors | Resigned | 2026-03-31 |
| Peter Hirth | member of the Board of Directors | Resigned | 2026-03-31 |
| Qasim Ahmad, M.D. | Chief Medical Officer | Terminated | 2026-01-30 |